15-63042874-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP2PP3PP5
The ENST00000403994.9(TPM1):c.45G>T(p.Lys15Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K15R) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000403994.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPM1 | NM_001018005.2 | c.45G>T | p.Lys15Asn | missense_variant | 1/10 | ENST00000403994.9 | NP_001018005.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPM1 | ENST00000403994.9 | c.45G>T | p.Lys15Asn | missense_variant | 1/10 | 1 | NM_001018005.2 | ENSP00000385107 | A1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 11, 2021 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this variant affects TPM1 protein function (PMID: 28732641; 26873245). This variant has been observed in individual(s) with dilated cardiomyopathy (PMID: 20215591, Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 31892). This variant is not present in population databases (ExAC no frequency). This sequence change replaces lysine with asparagine at codon 15 of the TPM1 protein (p.Lys15Asn). The lysine residue is moderately conserved and there is a moderate physicochemical difference between lysine and asparagine. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 01, 2012 | Variant classified as Uncertain Significance - Favor Pathogenic. The Lys15Asn va riant in TPM1 has been reported in 1 individual with DCM, was absent from 492 ra ce-matched control chromosomes (372 Caucasian) and segregated with disease in 2 other affected relatives (Hershberger 2010, Rampersaud 2011). In addition, this variant has been identified in 1 out of >3600 probands (>2200 Caucasian) tested by our laboratory and segregated with disease in 1 affected sibling (LMM unpubli shed data). The Lys15Asn variant has not been identified in large and broad popu lations by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS) ; this low frequency is consistent with a disease causing role but insufficient to establish this with confidence. Computational analyses (biochemical amino aci d properties, conservation, AlignGVGD, PolyPhen2, and SIFT) suggest that the Lys 15Asn variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the low frequency of this variant and segregation with disease suggest that it may be pathogenic, but additional information is needed to fully assess its clinical significance. - |
not provided Other:1
not provided, no classification provided | curation | Leiden Muscular Dystrophy (TPM1) | Apr 15, 2012 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at